The latest opinion pieces by industry thought leaders

  • Son holding father's hand at the hospital
    Image attribution tooltip
    FG Trade via Getty Images

    The power of the underdog: A rare disease nonprofit working to help patients win against the odds

    Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.

    Alexandra Pecci • July 13, 2022
  • SaNOtize CEO Gilly Regev
    Image attribution tooltip
    Permission granted by SaNOtize/Gilly Regev

    From vineyards to antivirals, Gilly Regev brings creative thinking to science

    The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.

    Alexandra Pecci • June 27, 2022
  • Image attribution tooltip
    Michael Ciaglo / Stringer via Getty Images

    Buoyed by COVID-19 shot, J&J's vaccines head sees a new golden age approaching

    Janssen’s goal to have ‘a vaccine for the world’ is part of what drew Penny Heaton to the company and its work.

    Alexandra Pecci • June 14, 2022
  • drug development
    Image attribution tooltip
    Stock via Getty Images

    After losing her daughter to a rare disease, Sharon King is looking to rewrite the playbook of drug development

    The communications pro is lending her community-building, storytelling expertise to the Bespoke Gene Therapy Consortium.

    Alexandra Pecci • June 7, 2022
  • Avak Kahvejian
    Image attribution tooltip

    Permission granted by Flagship Pioneering/Avak Kahvejian.

    Flagship's creative approach to finding the next big idea in biopharma

    Avak Kahvejian, partner at Flagship Pioneering, a company that conceives, creates and launches bioplatform companies like Moderna, discusses its latest venture, ProFound Therapeutics.

    Alexandra Pecci • June 1, 2022
  • SpringWorks Therapeutics chief medical officer Jim Cassidy
    Image attribution tooltip
    Permission granted by SpringWorks/Jim Cassidy

    Jumping into pharma with big plans at a small company

    SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.

    Alexandra Pecci • May 17, 2022
  • TauRx synapse
    Image attribution tooltip
    Permission granted by TauRx

    With the shine of amyloid fading, tau is a rising star in Alzheimer's

    The tau theory in Alzheimer's is being put to the test with phase 3 trial results due later this month from TauRx Pharmaceuticals.

    Michael Gibney • May 11, 2022
  • Medication nurse wearing protective gloves get a needle ready for an injection.
    Image attribution tooltip
    iStock via Getty Images

    Breaking new ground: Longhorn's trailblazing effort to develop a universal flu vaccine

    After years of success with their diagnostic platform for COVID-19, tuberculosis and the flu, the family funded company is shifting priorities back to the vaccine market.

    Taren Grom and Karissa Waddick • May 4, 2022
  • Image attribution tooltip
    Stock via Getty Images

    From cancer survivor to clinical trial innovator

    How Alicia Staley is using her insights as a three-time cancer survivor to drive clinical trial improvements at Medidata.

    Kelly Bilodeau • May 3, 2022
  • Headshot of Nelson Ambrogio.
    Image attribution tooltip

    Permission granted by Nelson Ambrogio.

    Bayer executive makes strides toward a finish line for rare cancers

    Bayer's SVP and general manager of U.S. oncology completed the Boston Marathon to honor his brother and bring attention to rare cancers.

    Alexandra Pecci • May 3, 2022
  • Image attribution tooltip

    Permission granted by Laura Randa. 

    Laura Randa's aim to break down mental healthcare barriers for disabled patients

    Despite the proliferation of mental health apps, many aren’t accessible for people with disabilities. The CEO of Toivoa plans to change that.

    Alexandra Pecci • April 27, 2022
  • White mouse in laboratory
    Image attribution tooltip
    D-Keine via Getty Images

    Mouse vs. machine: Using AI to solve the animal testing model in pharma

    Quris is bringing its first drug tested preclinically using AI — rather than animal models — into human trials.

    Michael Gibney • April 26, 2022
  • Image attribution tooltip

    Permission granted by Ted Love. 

    For Global Blood Therapeutics, the connection to sickle cell disease runs deep

    An underserved patient population is a guiding light for the company, which recently scored a new approval.

    Robin Robinson • April 19, 2022
  • Entos Chief Medical Officer Steve Chen
    Image attribution tooltip
    Permission granted by Entos/Steve Chen

    With Lilly on board, Entos' medical chief champions genetic platform with 'unlimited' potential

     Steve Chen is helping to lead Entos through an ‘inflection point’ in the development of its precision medicine delivery platform.

    Alexandra Pecci • April 14, 2022
  • Alnylam Pharmaceuticals CEO Yvonne Greenstreet
    Image attribution tooltip
    Permission granted by Alnylam/Yvonne Greenstreet

    Seeing yourself at the top: Alnylam CEO on why representation matters

    Dr. Yvonne Greenstreet became just the sixth woman in the world to head up a biopharma company with a market cap of more than $5 billion when she took on the role of CEO in January.

    Alexandra Pecci • April 6, 2022
  • Image attribution tooltip

    Permission granted by Alloy.

    From media to menopause: Creating new spaces in women's telehealth

    Why the former editor-in-chief of Marie Claire abandoned her magazine career to create a menopause-focused women's health startup.

    Alexandra Pecci • March 29, 2022
  • Image attribution tooltip

    Permission granted by Russell Potterfield.

    From angel to operator: The unlikely journey of Endevica Bio's CEO

    Russell Potterfield is honing his new found passion for the space to guide Endevica into the clinic.

    Jared Whitlock • March 9, 2022
  • Image attribution tooltip
    Stock via Getty Images

    Horizon's VP of R&D on her ascent in biotech — and bringing other female scientists along for the ride

    Elizabeth Thompson is guiding Horizon through new drug approvals while leading the way for young women in STEM.

    Alexandra Pecci • March 8, 2022
  • headshot
    Image attribution tooltip
    Permission granted by Guadalupe Hayes-Mota

    Guadalupe Hayes-Mota's 'recipe' for tackling pharma's supply chain issues

    A quest to expand access to medical treatment globally led to a new career path when Guadalupe Hayes-Mota left his biotech leadership roles to start his own company. 

    Robin Robinson • Feb. 25, 2022
  • Image attribution tooltip
    Stock via Getty Images

    How Veru is developing blockbuster drugs while avoiding biotech's 'valley of death'

    Why sexual health and telemedicine are key to the company's goals in oncology.

    Meagan Parrish • Feb. 16, 2022
  • Image attribution tooltip

    Permission granted by Blueprint Medicines

    Taking the leap and not having all the answers: How incoming CEO Kate Haviland plans to lead Blueprint

    For Haviland, success in biotech is about more than drug development.

    Alexandra Pecci • Jan. 28, 2022
  • headshot
    Image attribution tooltip
    Permission granted by Craig Lipset

    One man's quest to boost the patient's role in clinical trials

    How a personal diagnosis inspired Craig Lipset to transform patient involvement in medical research.

    Robin Robinson • Jan. 24, 2022
  • headshot
    Image attribution tooltip
    Retrieved from Google image.

    Evofem CEO Saundra Pelletier aims to level the playing field between men's and women's health

    Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women's health.

    Alexandra Pecci • Jan. 23, 2022
  • Image attribution tooltip
    Space Frontiers via Getty Images

    Vaxxinity looks to pioneer the next revolution in pharma

    With a one-of-a-kind platform and novel candidates for major indications, Vaxxinity wants to disrupt the industry’s paradigm of success. 

    Meagan Parrish • Jan. 14, 2022
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice

    PharmaVoice 100 Who's on the List – By Category

    Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...

    PharmaVoice Team • Aug. 1, 2021